Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03729375 · ClinicalTrials.gov registry record · Phase 1
The Effect Of An Anesthetic Procedure On Post Operative Pain Management In Carpal Tunnel Release
A Phase 1 study of Pain, Postoperative and Carpal Tunnel Syndrome, sponsored by University of South Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT03729375: Completed Phase 1 study of Pain, Postoperative and Carpal Tunnel Syndrome, sponsored by University of South Florida.
NCT03729375 is a Phase 1 study of Pain, Postoperative and Carpal Tunnel Syndrome that has completed, run by University of South Florida. The registered enrollment target is 52 participants, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03729375, a Phase 1 study of Pain, Postoperative and Carpal Tunnel Syndrome, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
Carpal Tunnel Syndrome patients undergoing carpal tunnel release surgery performed by the PI will receive intra-operative injections of bupivacaine (Marcaine). Two groups of patients will be randomly selected and will receive either 10cc or 20cc of injection. Their post-operative pain scores and usage of post-operative pain medication will be recorded and analyzed.
Primary Outcome
The investigator will implement a survey using a LIKERT scale regarding post-operative pain levels.
Conditions Studied
Interventions
- DRUG 10cc injection of bupivacaine
- DRUG 20cc injection of bupivacaine
Study Locations (1)
Florida
- University of South Florida Department of Orthopaedics - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2018-10-04 |
| Est. Completion | 2020-10-04 |
| Phase | Phase 1 |
What the finished NCT03729375 record still lists
NCT03729375 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 52 participants, a relatively small participant target, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which 10cc injection of bupivacaine is the first listed.
NCT03729375 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03729375 about?
NCT03729375 is a clinical study titled "The Effect Of An Anesthetic Procedure On Post Operative Pain Management In Carpal Tunnel Release". Carpal Tunnel Syndrome patients undergoing carpal tunnel release surgery performed by the PI will receive intra-operative injections of bupivacaine (Marcaine). Two groups of patients will be randomly selected and will receive either 10cc or 20cc of injection. Their post-operative pain scores and usa...
What is the current status of trial NCT03729375?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2018-10-04. Estimated completion is 2020-10-04.
What conditions does trial NCT03729375 study?
This clinical trial studies the following conditions: Pain, Postoperative, Carpal Tunnel Syndrome.
What interventions are being tested in trial NCT03729375?
The interventions under investigation include: 10cc injection of bupivacaine (DRUG), 20cc injection of bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03729375?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03729375 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03729375's enrollment target sits among peer trials
52 88th of 113 higher than 26 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Controlled Administration of Liquid Acetaminophen
RECRUITING · Phase 1
-
A Prospective Randomized Double Blind Trial to Assess the Effect of a Single Preoperative Dose of Gabapentin on Postoperative Opioid Consumption in Patients Undergoing Rhinoplasty
ACTIVE NOT RECRUITING · Phase 1
-
Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures
RECRUITING · NA
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02630121 · 52 participants · Phase 4
Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
- NCT03629171 · 52 participants · Phase 2
Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
- NCT04128748 · 52 participants · Phase 1
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- NCT04150497 · 52 participants · Phase 1
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI